Xanthelasma palpebrarum: A review and current management principles

Plastic and Reconstructive Surgery

Volumn 110, Issue 5, 2002, Pages 1310-1313

  Rohrich, Rod J ^a   Janis, Jeffrey E ^a   Pownell, Patrick H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRICHLOROACETIC ACID;

ALGORITHM; DIFFERENTIAL DIAGNOSIS; ESTHETIC SURGERY; EYELID; EYELID RECONSTRUCTION; EYELID XANTHELASMA; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SURGICAL TECHNIQUE; TREATMENT PLANNING; XANTHOMA;

EID: 0036785463     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000025626.70065.2b     Document Type: Review

References (24)

1. Cohen, P. R. Xanthelasma palpebrarum. J. Gt. Houst. Dent. Soc. 67: 10, 1996.
2. Jonsson, A., and Sigfusson, N. Significance of xanthelasma palpebrarum in the normal population (Letter). Lancet 1: 372, 1976.
3. Goldstein, J. L., and Brown, M. S. Familial hypercholesterolemia. In J. B. Stanbury, J. B. Wyngaarden, and D. S. Frederickson (Eds.), Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989.
4. Bergman, R. The pathogenesis and clinical significance of xanthelasma palpebrarum. J. Am. Acad. Dermatol. 30: 236, 1994.
5. Havel, R.J., and Kane, J. P. Introduction: Structure and metabolism of plasma lipoproteins. In J. B. Stanbury, J. B. Wyngaarden, and D. S. Frederickson (Eds.), Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989.
6. Alexander, L. J. Ocular signs and symptoms of altered blood lipids. J. Am. Optom. Assoc. 54: 123, 1983.
7. Cruz, P. D., Jr., East, C., and Bergstresser, P. R. Dermal, subcutaneous, and tendon xanthomas: Diagnostic markers for specific lipoprotein disorders. J. Am. Acad. Dermatol. 19: 95, 1988.
8. Fredrickson, D. S. Plasma lipid abnormalities in cutaneous and subcutaneous xanthoma. In T. B. Fitzpatrick (Ed.), Dermatology in General Medicine. New York: McGraw-Hill, 1971.
9. Havel, R. J., and Kane, J. P. Introduction: Structure and metabolism of plasma lipoproteins. In J. B. Stanbury, J. B. Wyngaarden, and D. S. Frederickson (Eds.), Metabolic Basis of Inherited Disease. New York: McGraw-Hill, 1989.
10. Pedace, F.J., and Winkelmann, R. K. Xanthelasma palpebrarum. J.A.M.A. 193: 893, 1965.
11. Walker, E.E., and Musselman, M. M. Xanthomas at sites of infection and trauma. Arch. Surg. 94: 39, 1967.
12. Vinger, P. F., and Sachs, B. A. Ocular manifestations of hyperlipoproteinemia. Am. J. Ophthalmol. 70: 563, 1970.
13. Kaplan, R. M., and Curtis, A. C. Xanthoma of the skin. JA.M.A. 176: 859, 1961.
14. Zarem, H. A., and Lorincz, A. L. Benign growths and generalized skin disorders. In W. C. Grabb and J. W. Smith (Eds.), Plastic Surgery: A Concise Guide to Clinical Practice, 2nd Ed. Boston: Little, Brown, 1973.
15. le Roux, P. Modified blepharoplasty incisions: Their use in xanthelasma. Br. J. Plast. Surg. 30: 81, 1977.
16. Parkes, M. L., and Waller, T. S. Xanthelasma palpebrarum. Laryngoscope 94: 1238, 1984.
17. Hosokawa, K., Susuki, T., Kikui, T. A., and Tahara, S. Treatment of large xanthomas by the use of blepharoplasty island musculocutaneous flaps. Ann. Plast. Surg. 18: 238, 1987.
18. 2 laser. Lasers Surg. Med. 24: 122, 1999.
19. 2 laser ablation of xanthelasma. J. Am. Acad. Dermatol. 34: 848, 1996.
20. Mannino, G., Papale, A., De Bella, F., Mollo, R., Morgia, P., and Gabrieli, C. B. Use of erbium:YAG laser in the treatment of palpebral xanthelasmas. Ophthalmic Surg. Lasers 32: 129, 2001.
21. 2 and erbium: YAG laser in eyelid surgery: A comparison [in German]. Ophthalmologe 97: 835, 2000.
22. Haygood, L. J., Bennett, J. D., and Brodell, R. T. Treatment of xanthelasma palpebrarum with bichloracetic acid. Dermatol. Surg. 24: 1027, 1998.
23. Jansen, G. T. Little tips with big rewards. J. Dermatol. Surg. 2: 243, 1976.
24. Mendelson, B. C., and Masson, J. K. Xanthelasma: Follow-up on results after surgical excision. Plast. Reconstr. Surg. 58: 535, 1976.